Tanglewood Legacy Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.9K Hold
2,072
0.02% 166
2026
Q1
$58.2K Hold
2,072
0.02% 158
2025
Q4
$51.6K Buy
2,072
+358
+21% +$9.03K 0.02% 161
2025
Q3
$43.7K Sell
1,714
-701
-29% -$17.3K 0.02% 175
2025
Q2
$58.5K Sell
2,415
-146
-6% -$3.4K 0.02% 162
2025
Q1
$64.9K Hold
2,561
0.03% 159
2024
Q4
$68K Hold
2,561
0.03% 153
2024
Q3
$74.1K Sell
2,561
-350
-12% -$10.2K 0.03% 135
2024
Q2
$81.5K Hold
2,911
0.04% 133
2024
Q1
$80.8K Sell
2,911
-1,141
-28% -$31.7K 0.04% 136
2023
Q4
$117K Sell
4,052
-200
-5% -$6.05K 0.06% 105
2023
Q3
$141K Hold
4,252
0.08% 98
2023
Q2
$156K Hold
4,252
0.09% 93
2023
Q1
$173K Hold
4,252
0.11% 78
2022
Q4
$218K Buy
+4,252
New +$204K 0.15% 54

Other funds holding PFE

Tanglewood Legacy Advisors's PFE Position: Q2 2026 in Review

Tanglewood Legacy Advisors held its Pfizer (PFE) position steady in Q2 2026 at 2,072 shares worth $49.9K. The position accounts for 0.02% of the portfolio, ranked #166.

Tanglewood Legacy Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $218K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tanglewood Legacy Advisors held 2,072 shares of Pfizer worth $49.9K as of Q2 2026.
  • Tanglewood Legacy Advisors left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.02% of Tanglewood Legacy Advisors's portfolio in Q2 2026, its #166 holding.
  • Tanglewood Legacy Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Tanglewood Legacy Advisors's Pfizer position peaked at $218K in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tanglewood Legacy Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.